OmniAb Investor Presentation Deck

Active Programs by Antibody Source Technology Omniflic 26% OmniChicken 14% Significant diversity of source OmniClic 3% 3% OmniMouse OmniTaur OmniRat 54% As of 3/31/2023, Combination of sources allocated to contributing source used based on percentage of end therapeutic 25 OmniAb

View entire presentation